Moderna has raised $1.8 b in total funding across 4 funding rounds for a $3 b valuation.

Moderna Capital Raised

Moderna Valuation

Source: The Wall Street Journal

Moderna Funding Rounds

DateAmount RaisedPost-money ValuationInvestors
UnattributedDec 2012$40 mFlagship Ventures
GrantOct 2013$24.6 mDARPA
UnattributedJan 2014$135 mAlexion Pharmaceuticals
Series EJan 2015$446.1 mWellington Management, Viking Global Investors, Invus, AstraZeneca, RA Capital Management, Alexion Pharmaceuticals
GrantJan 2016$20 mBill & Melinda Gates Foundation
Series FAug 2016$451.4 mAstraZeneca
GrantSept 2016$8 m$3 bBiomedical Advanced Research and Development Authority (BARDA)
Series GFeb 2018$500 m$7.5 bViking Global Investors, EDBI, BB Biotech Ventures, Pictet Private Equity Investors S.A., Fidelity Management and Research Company, Abu Dhabi Investment Authority, Alexandria Venture Investments, ArrowMark Partners, Sequoia Capital China, Julius Baer Group
Series HMay 2018$125 mMerck

Source: The Wall Street Journal

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu